Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (50)
Jingying Cao, Renxian Cao, Yiqi Liu & Tao Dai. (2023) CPNE1 mediates glycolysis and metastasis of breast cancer through activation of PI3K/AKT/HIF-1α signaling. Pathology - Research and Practice 248, pages 154634.
Crossref
Crossref
Shikha Rani, Andrew Lai, Soumya Nair, Shayna Sharma, Aase Handberg, Flavio Carrion, Andreas Möller & Carlos Salomon. (2023) Extracellular vesicles as mediators of cell-cell communication in ovarian cancer and beyond – A lipids focus. Cytokine & Growth Factor Reviews.
Crossref
Crossref
Oana Gabriela Trifanescu, Raluca Alexandra Trifanescu, Radu Iulian Mitrica, Diana Maria Bran, Georgia Luiza Serbanescu, Laurentiu Valcauan, Serban Andrei Marinescu, Laurentia Nicoleta Gales, Bogdan Cosmin Tanase & Rodica Maricela Anghel. (2023) The Female Reproductive Tract Microbiome and Cancerogenesis: A Review Story of Bacteria, Hormones, and Disease. Diagnostics 13:5, pages 877.
Crossref
Crossref
Kiran Kumar Aalapati, Amit Singh & Ranjana S.Patnaik. (2022) A Brief Review of Analytical Methods for the Estimation of Brivaracetam in Pharmaceutical Formulation and Biological Matrices. Journal of Advanced Zoology 43:1, pages 89-95.
Crossref
Crossref
Juliane M. Liberto, Sheng-Yin Chen, Ie-Ming Shih, Tza-Huei Wang, Tian-Li Wang & Thomas R. PisanicIIII. (2022) Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review. Cancers 14:12, pages 2885.
Crossref
Crossref
Brij Mohan, Sandeep Kumar, Hui Xi, Shixuan Ma, Zhiyu Tao, Tiantian Xing, Hengzhi You, Yang Zhang & Peng Ren. (2022) Fabricated Metal-Organic Frameworks (MOFs) as luminescent and electrochemical biosensors for cancer biomarkers detection. Biosensors and Bioelectronics 197, pages 113738.
Crossref
Crossref
Adrienn Sipos, Gyula Ujlaki, Edit Mikó, Eszter Maka, Judit Szabó, Karen Uray, Zoárd Krasznai & Péter Bai. (2021) The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Molecular Medicine 27:1.
Crossref
Crossref
Yashwanth Subbannayya, Riccardo Di Fiore, Silvana Anna Maria Urru & Jean Calleja-Agius. (2021) The Role of Omics Approaches to Characterize Molecular Mechanisms of Rare Ovarian Cancers: Recent Advances and Future Perspectives. Biomedicines 9:10, pages 1481.
Crossref
Crossref
Yousra Ahmed-Salim, Nicolas Galazis, Timothy Bracewell-Milnes, David L Phelps, Benjamin P Jones, Maxine Chan, Maria D Munoz-Gonzales, Tomoko Matsuzono, James Richard Smith, Joseph Yazbek, Jonathan Krell, Sadaf Ghaem-Maghami & Srdjan Saso. (2021) The application of metabolomics in ovarian cancer management: a systematic review. International Journal of Gynecologic Cancer 31:5, pages 754-774.
Crossref
Crossref
Yan-Ping Wang, Ting Wei, Xiao Ma, Xiao-Liang Zhu, Long-Fei Ren, Lei Zhang, Fang-Hui Ding, Xun Li, Hai-Ping Wang, Zhong-Tian Bai, Ke-Xiang Zhu, Long Miao, Jun Yan, Wen-Ce Zhou, Wen-Bo Meng & Yu-Qin Liu. (2021) Effect of Helicobacter Pylori on Plasma Metabolic Phenotype in Patients With Gastric Cancer. Cancer Control 28, pages 107327482110418.
Crossref
Crossref
Ruiyi Fan, Cheng Peng, Xinxin Zhang, Diyang Qiu, Genlin Mao, Yusheng Lu & Jiwu Zeng. (2020)
A comparative UPLC‐Q‐Orbitrap‐MS untargeted metabolomics investigation of different parts of
Clausena lansium
(Lour.) Skeels
. Food Science & Nutrition 8:11, pages 5811-5822.
Crossref
Crossref
Asia Saorin, Emanuela Di Gregorio, Gianmaria Miolo, Agostino Steffan & Giuseppe Corona. (2020) Emerging Role of Metabolomics in Ovarian Cancer Diagnosis. Metabolites 10:10, pages 419.
Crossref
Crossref
Richard D Semba. (2020) Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease. Advances in Nutrition 11:4, pages 760-772.
Crossref
Crossref
Igor Govorov, Stanislav Sitkin, Tatyana Pervunina, Alexey Moskvin, Denis Baranenko & Eduard Komlichenko. (2020) Metabolomic Biomarkers in Gynecology: A Treasure Path or a False Path?. Current Medicinal Chemistry 27:22, pages 3611-3622.
Crossref
Crossref
Oana A Zeleznik, Clary B Clish, Peter Kraft, Julian Avila-Pacheco, A Heather Eliassen & Shelley S Tworoger. (2020) Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study. JNCI: Journal of the National Cancer Institute 112:6, pages 628-636.
Crossref
Crossref
Kyoung Hee Han, Bora Kim, Sang Chun Ji, Hee Gyung Kang, Hae Il Cheong, Joo-Youn Cho & Il-Soo Ha. (2020) Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis. Metabolites 10:4, pages 169.
Crossref
Crossref
Elin Strand, Ingvild L. Tangen, Kristine E. Fasmer, Havjin Jacob, Mari K. Halle, Erling A. Hoivik, Bert Delvoux, Jone Trovik, Ingfrid S. Haldorsen, Andrea Romano & Camilla Krakstad. (2019) Blood Metabolites Associate with Prognosis in Endometrial Cancer. Metabolites 9:12, pages 302.
Crossref
Crossref
Danning Huang, David A. Gaul, Hongmei Nan, Jaeyeon Kim & Facundo M. Fernández. (2019) Deep Metabolomics of a High-Grade Serous Ovarian Cancer Triple-Knockout Mouse Model. Journal of Proteome Research 18:8, pages 3184-3194.
Crossref
Crossref
Xin Lu, Yiqun Li, Bairong Xia, Yunfan Bai, Kun Zhang, Xiaohan Zhang, Hongyu Xie, Fengyu Sun, Yan Hou & Kang Li. (2019) Selection of small plasma peptides for the auxiliary diagnosis and prognosis of epithelial ovarian cancer by using UPLC/MS‐based nontargeted and targeted analyses. International Journal of Cancer 144:8, pages 2033-2042.
Crossref
Crossref
Faris Matanes, Waleed O. Twal & Samar M. Hammad. 2019. Bioactive Ceramides in Health and Disease. Bioactive Ceramides in Health and Disease
109
138
.
Gunjal Garg, Ali Yilmaz, Praveen Kumar, Onur Turkoglu, David G. Mutch, Matthew A. Powell, Barry Rosen, Ray O. Bahado-Singh & Stewart F. Graham. (2018) Targeted metabolomic profiling of low and high grade serous epithelial ovarian cancer tissues: a pilot study. Metabolomics 14:12.
Crossref
Crossref
Dževad Belkić & Karen Belkić. (2018) Validation of reconstructed component spectra from non-parametric derivative envelopes: comparison with component lineshapes from parametric derivative estimations with the solved quantification problem. Journal of Mathematical Chemistry 56:8, pages 2537-2578.
Crossref
Crossref
Nguyen Phuoc Long, Sang Jun Yoon, Nguyen Hoang Anh, Tran Diem Nghi, Dong Kyu Lim, Yu Jin Hong, Soon-Sun Hong & Sung Won Kwon. (2018) A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer. Metabolomics 14:8.
Crossref
Crossref
Andrea Rizzo, Alessandra Napoli, Francesca Roggiani, Antonella Tomassetti, Marina Bagnoli & Delia Mezzanzanica. (2018) One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer. International Journal of Molecular Sciences 19:7, pages 2092.
Crossref
Crossref
Nejc Kozar, Kristi Kruusmaa, Marko Bitenc, Rosa Argamasilla, Antonio Adsuar, Nandu Goswami, Darja Arko & Iztok Takač. (2018) Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer. Clinica Chimica Acta 481, pages 108-114.
Crossref
Crossref
Fan Zhang, Yuanyuan Zhang, Chaofu Ke, Ang Li, Wenjie Wang, Kai Yang, Huijuan Liu, Hongyu Xie, Kui Deng, Weiwei Zhao, Chunyan Yang, Ge Lou, Yan Hou & Kang Li. (2018) Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery. Metabolomics 14:5.
Crossref
Crossref
Kun Shi, Qiong Wang, Yao Su, Xingcui Xuan, Yaqiong Liu, Weiwei Chen, Yuanmin Qian & Gendie E. Lash. (2018) Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma. Cancer Science 109:4, pages 1032-1043.
Crossref
Crossref
Hongxue Sun, Jiaying Zhao, Di Zhong & Guozhong Li. (2017) Potential serum biomarkers and metabonomic profiling of serum in ischemic stroke patients using UPLC/Q-TOF MS/MS. PLOS ONE 12:12, pages e0189009.
Crossref
Crossref
Lina Wang, Xin Wang, Ying Li, Yan Hou, Fengyu Sun, Shuang Zhou, Chunming Li & Bin Zhang. (2017) Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma. Oncotarget 8:54, pages 92324-92332.
Crossref
Crossref
Xidong Shao, Ke Wang, Xinyu Liu, Caiyun Gu, Pengjie Zhang, Jiabin Xie, Wenxin Liu, Lu Sun, Tong Chen & Yubo Li. (2016) Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS. Clinica Chimica Acta 463, pages 200-206.
Crossref
Crossref
Gita Chawla & Chanda Ranjan. (2016) Principle, Instrumentation, and Applications of UPLC: A Novel Technique of Liquid Chromatography. Open Chemistry Journal 3:1, pages 1-16.
Crossref
Crossref
Onur Turkoglu, Amna Zeb, Stewart Graham, Thomas Szyperski, J. Brian Szender, Kunle Odunsi & Ray Bahado-Singh. (2016) Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature. Metabolomics 12:4.
Crossref
Crossref
Chaofu Ke, Ang Li, Yan Hou, Meng Sun, Kai Yang, Jinlong Cheng, Jingtao Wang, Tingting Ge, Fan Zhang, Qiang Li, Junnan Li, Ying Wu, Ge Lou & Kang Li. (2016) Metabolic phenotyping for monitoring ovarian cancer patients. Scientific Reports 6:1.
Crossref
Crossref
Kelly H. Telu, Xinjian Yan, William E. Wallace, Stephen E. Stein & Yamil Simón-Manso. (2016) Analysis of human plasma metabolites across different liquid chromatography/mass spectrometry platforms: Cross-platform transferable chemical signatures. Rapid Communications in Mass Spectrometry 30:5, pages 581-593.
Crossref
Crossref
Yan Hou, Junnan Li, Hongyu Xie, Fengyu Sun, Kai Yang, Jingtao Wang, Chaofu Ke, Ge Lou & Kang Li. (2015) Differential plasma lipids profiling and lipid signatures as biomarkers in the early diagnosis of ovarian carcinoma using UPLC-MS. Metabolomics 12:2.
Crossref
Crossref
Laila M Poisson, Adnan Munkarah, Hala Madi, Indrani Datta, Sharon Hensley-Alford, Calvin Tebbe, Thomas Buekers, Shailendra Giri & Ramandeep Rattan. (2015) A metabolomic approach to identifying platinum resistance in ovarian cancer. Journal of Ovarian Research 8:1.
Crossref
Crossref
Suzanne Miyamoto, Sandra Taylor, Dinesh Barupal, Ayumu Taguchi, Gert Wohlgemuth, William Wikoff, Ken Yoneda, David Gandara, Samir Hanash, Kyoungmi Kim & Oliver Fiehn. (2015) Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry. Metabolites 5:2, pages 192-210.
Crossref
Crossref
Christina M. Jones, María Eugenia Monge, Jaeyeon Kim, Martin M. Matzuk & Facundo M. Fernández. (2015) Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model. Journal of Proteome Research 14:2, pages 917-927.
Crossref
Crossref
Hongmin ZhaoWei WeiYuhui SunJianhua GaoQi WangJianhua Zheng. (2015) Interference with the Expression of β-Catenin Reverses Cisplatin Resistance in A2780/DDP Cells and Inhibits the Progression of Ovarian Cancer in Mouse Model. DNA and Cell Biology 34:1, pages 55-62.
Crossref
Crossref
Haiyu Zhang, Tingting Ge, Xiaoming Cui, Yan Hou, Chaofu Ke, Meng Yang, Kai Yang, Jingtao Wang, Bing Guo, Fan Zhang, Ge Lou & Kang Li. (2015) Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling. Molecular BioSystems 11:2, pages 516-521.
Crossref
Crossref
Sang Hoon Song, Minje Han, Yang Seon Choi, Ki Soon Dan, Man Gil Yang, Junghan Song, Sung Sup Park & Jae Ho Lee. (2014) Proteomic Profiling of Serum from Patients with Tuberculosis. Annals of Laboratory Medicine 34:5, pages 345-353.
Crossref
Crossref
Chaofu Ke, Yan Hou, Haiyu Zhang, Lijun Fan, Tingting Ge, Bing Guo, Fan Zhang, Kai Yang, Jingtao Wang, Ge Lou & Kang Li. (2014) Large-scale profiling of metabolic dysregulation in ovarian cancer. International Journal of Cancer, pages n/a-n/a.
Crossref
Crossref
Douglas B. Kell & Royston Goodacre. (2014) Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery. Drug Discovery Today 19:2, pages 171-182.
Crossref
Crossref
Felix Leung, Eleftherios P. Diamandis & Vathany Kulasingam. 2014.
25
77
.
David B. Liesenfeld, Nina Habermann, Robert W. Owen, Augustin Scalbert & Cornelia M. Ulrich. (2013) Review of Mass Spectrometry–Based Metabolomics in Cancer Research. Cancer Epidemiology, Biomarkers & Prevention 22:12, pages 2182-2201.
Crossref
Crossref
Luc Denoroy, Luc Zimmer, Bernard Renaud & Sandrine Parrot. (2013) Ultra high performance liquid chromatography as a tool for the discovery and the analysis of biomarkers of diseases: A review. Journal of Chromatography B 927, pages 37-53.
Crossref
Crossref
Mukesh Verma, Muin J. Khoury & John P.A. Ioannidis. (2013) Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling. Cancer Epidemiology, Biomarkers & Prevention 22:2, pages 189-200.
Crossref
Crossref
. (2013) Current World Literature. Current Opinion in Obstetrics & Gynecology 25:1, pages 81-89.
Crossref
Crossref
Felix Leung, Natasha Musrap, Eleftherios P. Diamandis & Vathany Kulasingam. (2013) Advances in mass spectrometry-based technologies to direct personalized medicine in ovarian cancer. Translational Proteomics 1:1, pages 74-86.
Crossref
Crossref
Jeremy K. Nicholson, Elaine Holmes, James M. Kinross, Ara W. Darzi, Zoltan Takats & John C. Lindon. (2012) Metabolic phenotyping in clinical and surgical environments. Nature 491:7424, pages 384-392.
Crossref
Crossref